Viewing Study NCT02093260


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-03-11 @ 12:56 AM
Study NCT ID: NCT02093260
Status: COMPLETED
Last Update Posted: 2015-04-29
First Post: 2014-03-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)
Sponsor: PT Bio Farma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Influenza 0213
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators